Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. - Suppr | 超能文献

Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.

作者信息

González-Juanatey J R, Pose Reino A, Román A V, García Acuña J M, Fernández López J A, Cerrato J C

机构信息

Cardiology Department and Hypertension Unit, Complejo Hospitalario Universitario, La Coruna, Spain.

出版信息

Am J Cardiol. 1997 Feb 1;79(3):373-6. doi: 10.1016/s0002-9149(96)00767-9.

DOI:10.1016/s0002-9149(96)00767-9

Abstract

Continued treatment of hypertensive patients with enalapril reduced left ventricular (LV) hypertrophy steadily over a period of 5 years (by which time gross structural parameters were normal) and produced no further reduction during the following 2 years. Temporary suspension of treatment after 5-year follow-up gave rise to an increase in blood pressure, and to deterioration of LV isovolumic relaxation time and deceleration of the ventricular filling E wave, both of which chiefly reflect the active relaxation of the ventricle.

摘要

相似文献

1

Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.

Am J Cardiol. 1997 Feb 1;79(3):373-6. doi: 10.1016/s0002-9149(96)00767-9.

2

Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.

Am J Cardiol. 1998 Jan 1;81(1):87-90. doi: 10.1016/s0002-9149(97)00860-6.

3

Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).

Am J Cardiol. 1996 Jul 1;78(1):61-5. doi: 10.1016/s0002-9149(96)00228-7.

4

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).

Am J Hypertens. 2006 Sep;19(9):927-36. doi: 10.1016/j.amjhyper.2006.02.009.

5

Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.

J Card Fail. 1995 Dec;1(5):365-70. doi: 10.1016/s1071-9164(05)80005-3.

6

Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.

Int J Clin Pharmacol Ther. 1994 Jun;32(6):312-6.

7

Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.

Hypertension. 2006 May;47(5):868-73. doi: 10.1161/01.HYP.0000215578.40687.6f. Epub 2006 Mar 27.

8

Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.

Ann Noninvasive Electrocardiol. 2003 Jan;8(1):47-54. doi: 10.1046/j.1542-474x.2003.08108.x.

9

[A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].

Cardiologia. 1993 Sep;38(9):585-91.

10

ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.

Nephrol Dial Transplant. 1997 May;12(5):945-51. doi: 10.1093/ndt/12.5.945.

引用本文的文献

1

Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril.

Ann Noninvasive Electrocardiol. 2003 Jan;8(1):47-54. doi: 10.1046/j.1542-474x.2003.08108.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。